Founded by Gil Aharon Ph.D. and Steven Salamon P.Eng. CFA in Toronto, Canada, Rosalind Advisors, Inc. manages life-sciences focused funds. Our biotech funds’ strategy is market agnostic, operating at the intersection of science and finance with the goal of capitalizing on consistent market inefficiencies and arbitrage opportunities. Since its founding in 2006, the fund has had a consistent track-record of uncorrelated abnormal returns.